Drug Profile
AL 704
Alternative Names: AL-704; ALS 022704; JNJ 54257099Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Medivir AB
- Developer Janssen Infectious Diseases BVBA
- Class Antivirals; Nucleosides
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C